Medicis Pharmaceutical Corp. (MRX) Tops Q4 EPS by 15c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $70.85 --0%
Financial Fact:
Research And Development Expense: 12.26M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Research And Development Expense: 12.26M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q4 EPS of $0.76, $0.15 better than the analyst estimate of $0.61. Revenue for the quarter came in at $415.6 million versus the consensus estimate of $370.72 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- TORM plc (TRMD) Misses Q2 EPS by 5c; updates guidance
- Zhihu Inc. (ZH) Reports Q2 Revenue Below Estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
